Investment
Features
FeesSafety
Academy
More
Pluang+

Compare H World Group Limited American Depositary Shares (HTHT) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance

H World Group Limited American Depositary SharesTrade
Regeneron Pharmaceuticals IncTrade

Price performance (Past 24H)

Key statistics

H World Group Limited American Depositary Shares vs Regeneron Pharmaceuticals Inc — how do they compare? H World Group Limited American Depositary Shares trades at $44.16 (market cap $13.25B), while Regeneron Pharmaceuticals Inc trades at $746.54 (market cap $76.14B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 5.7× H World Group Limited American Depositary Shares's market cap, and H World Group Limited American Depositary Shares pays the higher dividend (5.08%). Which is the better fit depends on your goals — on Pluang, investors hold H World Group Limited American Depositary Shares for 1 Days and Regeneron Pharmaceuticals Inc for 107 Days on average.

HTHTREGN
Market Cap
$13.25B$76.14B
Volume
1,177,261500,239
Sector
Consumer CyclicalHealth
52-Week High
$56.06$852.03
52-Week Low
$36.99$557.73
Typical Hold Time
1 Days107 Days
Enterprise Value
$16.03B$70.85B
Dividend Yield
5.08%0.51%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

H World Group Limited American Depositary Shares

No Aura AI signal available yet.

Regeneron Pharmaceuticals Inc

Regeneron Pharmaceuticals (REGN) trades at $739.57, down 0.34% with a bearish technical signal. The company maintains strong fundamentals with a 27.86% net income margin and consistent earnings beats. Recent news highlights a significant $8 billion immunology alliance expansion with Sanofi, providing substantial upfront payments and milestone potential. Cash flow improved significantly in 2025 with $635 million net cash flow versus negative flows in prior years.

The stock presents a compelling investment case with strong profitability, positive analyst sentiment (69% buy ratings), and a $849.84 consensus price target offering 15% upside. Key risks include competitive pressures in ophthalmology drugs and reliance on key partnerships. The expanded Sanofi collaboration and promising clinical pipeline provide catalysts for growth.

Returns comparison

Trailing returns across standard periods

About H World Group Limited American Depositary Shares

H World Group operates hotels through leased and owned, managed franchise, and franchise models. Its brands include HanTing, JI Hotel, Orange Hotel, and Steigenberger Hotels & Resorts.

Read more on HTHT →

About Regeneron Pharmaceuticals Inc

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases

Read more on REGN →